Characterization of cognition alteration across the course of the disease in APP751SL mice with parallel estimation of cerebral Aβ deposition

Behavioural Brain Research

Volumn 201, Issue 1, 2009, Pages 147-157

  Blanchard, Julie ^a,b   Decorte, Laurence ^a   Noguès, Xavier ^a   Micheau, Jacques ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

A deposition; Alzheimer disease; APP751SL mice; Behavior; Consolidation; Hippocampus; Memory; Zif268

Indexed keywords

AMYLOID BETA PROTEIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; APPETITE; ARTICLE; BEHAVIOR; BODY WEIGHT; BRAIN REGION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; EXPLORATORY BEHAVIOR; IMMUNOHISTOCHEMISTRY; INSTRUMENTAL CONDITIONING; LEARNING DISORDER; MALE; MENTAL DETERIORATION; MOTOR ACTIVITY; MOUSE; MUSCLE STRENGTH; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; REFERENCE MEMORY; REINFORCEMENT; SPATIAL MEMORY; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANXIETY; BODY WEIGHT; BRAIN; COGNITION DISORDERS; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; EARLY GROWTH RESPONSE PROTEIN 1; EXPLORATORY BEHAVIOR; HUMANS; MALE; MAZE LEARNING; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; RECEPTORS, CELL SURFACE; SPACE PERCEPTION;

EID: 64849083495     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.02.005     Document Type: Article

References (65)

1. Albert M.S. Cognitive and neurobiologic markers of early Alzheimer disease. Proc Natl Acad Sci U S A 93 (1996) 13547-13551
2. Arendash G.W., King D.L., Gordon M.N., Morgan D., Hatcher J.M., Hope C.E., et al. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res 891 (2001) 42-53
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC, 1994.
4. 751SL mice results in cue-guided response. Neurobiol Aging 29 (2008) 1011-1021
5. Blanchard V., Moussaoui S., Czech C., Touchet N., Bonici B., Planche M., et al. Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp Neurol 184 (2003) 247-263
6. Bloom F.E., Reilly J.F., Redwine J.M., Wu C.C., Young W.G., and Morrison J.H. Mouse models of human neurodegenerative disorders: requirements for medication development. Arch Neurol 62 (2005) 185-187
7. Bozon B., Davis S., and Laroche S. A requirement for the immediate early gene zif268 in reconsolidation of recognition memory and retrieval. Neuron 40 (2003) 695-701
8. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82 (1991) 239-259
9. Buhot M.C., Dubayle D., Malleret G., Javerzat S., and Segu L. Exploration anxiety, and spatial memory in transgenic anophthalmic mice. Behav Neurosci 115 (2001) 455-467
10. Chen G., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J., et al. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408 (2000) 975-979
11. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P., Pearson J., et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276 (2001) 21562-21570
12. Cummings B.J., and Cotman C.W. Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet 346 (1995) 1524-1528
13. de Bruin J.P., Moita M.P., de Brabander H.M., and Joosten R.N. Place and response learning of rats in a Morris water maze: differential effects of fimbria fornix and medial prefrontal cortex lesions. Neurobiol Learn Mem 75 (2001) 164-178
14. Delatour B., and Gisquet-Verrier P. Functional role of rat prelimbic-infralimbic cortices in spatial memory: evidence for their involvement in attention and behavioural flexibility. Behav Brain Res 109 (2000) 113-128
15. Destrade C., and Cardo B. Effects of post-trial hippocampal stimulation on time-dependent improvement of performance in mice. Brain Res 78 (1974) 447-454
16. Destrade C., Soumireu-Mourat B., and Cardo B. Effects of posttrial hippocampal stimulation on acquisition of operant behavior in the mouse. Behav Biol 8 (1973) 713-724
17. Dodart J.C., Meziane H., Mathis C., Bales K.R., Paul S.M., and Ungerer A. Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Behav Neurosci 113 (1999) 982-990
18. Franklin K.B., and Paxinos G. The mouse brain in stereotaxic coordinates (1996), Academic Press, San Diego (CA)
19. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373 (1995) 523-527
20. Giannakopoulos P., Herrmann F.R., Bussiere T., Bouras C., Kovari E., Perl D.P., et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60 (2003) 1495-1500
21. Granon S., and Poucet B. Medial prefrontal lesions in the rat and spatial navigation: evidence for impaired planning. Behav Neurosci 109 (1995) 474-484
22. Guillou J.L., Micheau J., and Jaffard R. Intrahippocampal injections of cysteamine improve the retention of a bar pressing task in mice. Behav Brain Res 103 (1999) 113-117
23. Guillozet A.L., Weintraub S., Mash D.C., and Mesulam M.M. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 60 (2003) 729-736
24. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
25. Harper D.G., Volicer L., Stopa E.G., McKee A.C., Nitta M., and Satlin A. Disturbance of endogenous circadian rhythm in aging and Alzheimer disease. Am J Geriatr Psychiatry 13 (2005) 359-368
26. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4 (1998) 97-100
27. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
28. Huitron-Resendiz S., Sanchez-Alavez M., Gallegos R., Berg G., Crawford E., Giacchino J.L., et al. Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice. Brain Res 928 (2002) 126-137
29. Jacobsen J.S., Wu C.C., Redwine J.M., Comery T.A., Arias R., Bowlby M., et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 103 (2006) 5161-5166
30. Jaffard R., Destrade C., Soumireu-Mourat B., and Cardo B. Time-dependent improvement of performance on appetitive tasks in mice. Behav Biol 11 (1974) 89-100
31. Janus C., Chishti M.A., and Westaway D. Transgenic mouse models of Alzheimer's disease. Biochim Biophys Acta 1502 (2000) 63-75
32. Janus C., Welzl H., Hanna A., Lovasic L., Lane N., St George-Hyslop P., et al. Impaired conditioned taste aversion learning in APP transgenic mice. Neurobiol Aging 25 (2004) 1213-1219
33. Jarrard L.E., Feldon J., Rawlins J.N.P., Sinden J.D., and Gray J.A. The effects of intrahippocampal ibotenate on resistance to extinction after continuous or partial reinforcement. Exp Brain Res 61 (1986) 519-530
34. Johnson-Wood K., Lee M., Motter R., Hu K., Gordon G., Barbour R., et al. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci U S A 94 (1997) 1550-1555
35. Kelly P.H., Bondolfi L., Hunziker D., Schlecht H.P., Carver K., Maguire E., et al. Progressive age-related impairment of cognitive behavior in APP23 transgenic mice. Neurobiol Aging 24 (2003) 365-378
36. Lalonde R., Dumont M., Staufenbiel M., Sturchler-Pierrat C., and Strazielle C. Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation. Brain Res 956 (2002) 36-44
37. Lalonde R., Qian S., and Strazielle C. Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination. Behav Brain Res 138 (2003) 71-79
38. 751SL transgenic mice. Genes Brain Behav 7 Suppl. 1 (2008) 83-91
39. Lee K.W., Lee S.H., Kim H., Song J.S., Yang S.D., Paik S.G., et al. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein. J Neurosci Res 76 (2004) 572-580
40. Lesné S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
41. Lyketsos C.G., Lopez O., Jones B., Fitzpatrick A.L., Breitner J., and DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 288 (2002) 1475-1483
42. McDonald R.J., and White N.M. Parallel information processing in the water maze: evidence for independent memory systems involving dorsal striatum and hippocampus. Behav Neural Biol 61 (1994) 260-270
43. McGowan E., Eriksen J., and Hutton M. A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet 22 (2006) 281-289
44. Moechars D., Dewachter I., Lorent K., Reverse D., Baekelandt V., Naidu A., et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274 (1999) 6483-6492
45. Morris J.C., and Rubin E.H. Clinical diagnosis and course of Alzheimer's disease. Psychiatr Clin North Am 14 (1991) 223-236
46. Naslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283 (2000) 1571-1577
47. Oddo S., Caccamo A., Smith I.F., Green K.N., and LaFerla F.M. A dynamic relationship between intracellular and extracellular pools of Abeta. Am J Pathol 168 (2006) 184-194
48. Oddo S., Caccamo A., Tran L., Lambert M.P., Glabe C.G., Klein W.L., et al. Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem 281 (2006) 1599-1604
49. Palmer K., Berger A.K., Monastero R., Winblad B., Backman L., and Fratiglioni L. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 68 (2007) 1596-1602
50. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
51. Piolino P., Giffard-Quillon G., Desgranges B., Chételat G., Baron J.C., and Eustache F. Re-experiencing old memories via hippocampus: a PET study of autobiographical memory. NeuroImage 22 (2004) 1371-1383
52. Price D.L., and Sisodia S.S. Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 21 (1998) 479-505
53. Puoliväli J., Wang J., Heikkinen T., Heikkila M., Tapiola T., van Groen T., et al. Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice. Neurobiol Dis 9 (2002) 339-347
54. Rockenstein E., Mallory M., Mante M., Sisk A., and Masliaha E. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). J Neurosci Res 66 (2001) 573-582
55. Rutten B.P., Van der Kolk N.M., Schafer S., van Zandvoort M.A., Bayer T.A., Steinbusch H.W., et al. Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice. Am J Pathol 167 (2005) 161-173
56. Schmitz C., Rutten B.P., Pielen A., Schafer S., Wirths O., Tremp G., et al. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am J Pathol 164 (2004) 1495-1502
57. Selkoe D.J. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. J Clin Invest 110 (2002) 1375-1381
58. Spires T.L., and Hyman B.T. Transgenic models of Alzheimer's disease: learning from animals. NeuroRx 2 (2005) 423-437
59. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C., Rothacher S., et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A 94 (1997) 13287-13292
60. Thal D.R., Rub U., Orantes M., and Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58 (2002) 1791-1800
61. Van Dam D., D'Hooge R., Staufenbiel M., Van Ginneken C., Van Meir F., and De Deyn P.P. Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur J Neurosci 17 (2003) 388-396
62. Van Dam D., and De Deyn P.P. Drug discovery in dementia: the role of rodent models. Nat Rev Drug Discov 5 (2006) 956-970
63. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 22 (2002) 1858-1867
64. White N.M., and McDonald R.J. Multiple parallel memory systems in the brain of the rat. Neurobiol Learn Mem 77 (2002) 125-184
65. Wirths O., Multhaup G., Czech C., Blanchard V., Moussaoui S., Tremp G., et al. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci Lett 306 (2001) 116-120